BPC-157 + TB-500 blend

Wolverine

Repair · Actin

Wolverine is a trade name for a BPC-157 and TB-500 combination. No peer-reviewed study has tested this fixed blend as a single intervention; claims are often incorrectly extrapolated from separate component studies.

2Overview
1× / dayReference frequency
DataComponent data; mainly preclinical
Research status

No direct clinical study of the blend

Velora Wolverine vial
WOLVERINE10 MG
01 · Overview

What is Wolverine?

Wolverine is a trade name for a BPC-157 and TB-500 combination. No peer-reviewed study has tested this fixed blend as a single intervention; claims are often incorrectly extrapolated from separate component studies.

Research route, formulation and population determine what a result actually means.

01

Repair

Studies cell migration, vessel formation and matrix repair in wound models.

02

Actin

Thymosin-β4 binds actin and influences cell migration and wound repair.

Protocol status: Not found as a standalone product page in the previously used protocol source. No protocol has been invented; only a transparent calculation reference is shown where technically meaningful.
02 · Research

What do the studies show?

Component data; mainly preclinical. Educational information. Not diagnosis, treatment or use advice.

03 · DATA

Peptide and product specifications

Checked identity data for this research compound or blend.

WolverinePeptide and product specifications
Product type
Blend; not a single molecule
Components
BPC-157 + TB-500
Nominal composition
The exact split for 10 mg and 20 mg must be stated on the Velora label/COA
Combined molecular formula
Not applicable to a blend
Combined CAS number
None; see the individual component pages
Purity
Batch-specific - confirm identity and purity with the Velora COA
Reference diluent
Formulation- and batch-specific; there is no universal diluent for every research compound
Unreconstituted-material storage
Follow the accompanying COA, product label and validated stability data

These are compound references, not a batch certificate. Purity and identity of a specific Velora batch must be confirmed by its accompanying COA and laboratory report.

04 · Calculator

Reconstitution and U-100 conversion

This module only converts concentration and volume. Inputs are not recommendations or individual dosing advice.

Calculator

Once daily in educational blend protocols

1
2
3
4
Draw to
0 units
0.00 mL
Wolverine vial
WOLVERINE
10 MG
Concentration-
Per unit-
Complete amounts-
Calculated duration-
LAB · RECONSTITUTION

How to reconstitute Wolverine for laboratory research

A visual workflow for controlled laboratory reconstitution. Always follow the product label, COA and a validated protocol.

Five visual laboratory reconstitution steps: clean, measure diluent, add slowly, swirl gently and store according to protocol.
1

Clean

Disinfect the rubber closures of both vials and allow them to dry.

2

Measure diluent

Withdraw only the diluent validated for the specific compound.

3

Add slowly

Let the liquid run slowly down the inside wall of the vial.

4

Swirl gently

Do not shake; rotate gently until the material has dissolved.

5

Store per protocol

Follow the product label, COA and validated stability data.

Important checks before and after reconstitution

Check the product

First confirm that the product is a lyophilised vial. Prefilled pens and ready-to-use solutions do not require reconstitution. Check the label, COA and specified diluent.

Use clean, sterile technique

Wash your hands, clean the work surface and use new sterile equipment for every procedure. Clean both rubber closures with separate alcohol swabs and let them dry completely.

Concentration, not total amount

The volume of liquid added changes the concentration in mg per mL, but not the total amount of research compound in the vial. Use the calculator to check this in advance.

Inspect and label

Check for unexpected discoloration, cloudiness or visible particles. Record the compound, concentration and reconstitution date. Storage time and temperature are product-specific; a fixed 28-day rule does not apply to every compound.

General reconstitution volumes listed by the source

General examples, not a product-specific protocol. The chosen volume determines concentration; always check the label, COA and calculator.

Vial strengthCommonly listed volume
2 mg1–2 mL
5 mg2–3 mL
6 mg2–3 mL
10 mg2–4 mL
15 mg3–5 mL
20 mg4–8 mL

Practical background source: Free Medical Journals - Complete Step-by-Step Guide to Peptide Reconstitution, accessed July 2026. This is a secondary educational source; the product label, COA and validated stability data remain authoritative.

Protocol status: Not found as a standalone product page in the previously used protocol source. No protocol has been invented; only a transparent calculation reference is shown where technically meaningful.
05 · Safety and limitations

Safety and limitations

Research route, formulation and population determine what a result actually means.

What is known

  • Visible research claims use primary or official sources.
  • The calculator is arithmetic and does not turn a study amount into medical advice.
  • A registered medicine and a research vial are not automatically equivalent.

What remains uncertain

  • Many products lack long-term safety data and independent replication.
  • Animal and cell findings do not predict a safe human dose.
  • Stability depends on formulation, pH, sterility, light, temperature and packaging.
Status: No direct clinical study of the blend. Educational information. Not diagnosis, treatment or use advice.
06 · FAQ

Frequently asked questions

Wolverine is a trade name for a BPC-157 and TB-500 combination. No peer-reviewed study has tested this fixed blend as a single intervention; claims are often incorrectly extrapolated from separate component studies.
Synergy, optimal ratio and combined-use safety have not been established clinically. BPC-157 claims mainly come from animal models; human wound research largely concerns full thymosin-β4, not necessarily TB-500.
No. It performs arithmetic conversions only. Medical decisions belong with a licensed healthcare professional.
The curve follows the agreed storage model and is not a laboratory result.
2–8 °C. Protect from light and repeated freeze-thaw cycles.
07 · Sources

Primary research sources

Educational information. Not diagnosis, treatment or use advice.

Thymosin beta4 accelerates wound healing Journal of Investigative Dermatology, 1999. Link
Thymosin beta4 treatment of venous ulcers Annals of the New York Academy of Sciences, 2010. Link